Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.

Punt S, Corver WE, van der Zeeuw SA, Kielbasa SM, Osse EM, Buermans HP, de Kroon CD, Jordanova ES, Gorter A.

Oncotarget. 2015 Nov 17;6(36):38681-94. doi: 10.18632/oncotarget.4526.

2.

Signatures of accelerated somatic evolution in gene promoters in multiple cancer types.

Smith KS, Yadav VK, Pedersen BS, Shaknovich R, Geraci MW, Pollard KS, De S.

Nucleic Acids Res. 2015 Jun 23;43(11):5307-17. doi: 10.1093/nar/gkv419. Epub 2015 May 1.

3.

The long journey of TCL1 transgenic mice: lessons learned in the last 15 years.

Pekarsky Y, Drusco A, Kumchala P, Croce CM, Zanesi N.

Gene Expr. 2015;16(3):129-35. doi: 10.3727/105221615X14181438356256. Review.

4.

Somatic stem cells and their dysfunction in endometriosis.

Djokovic D, Calhaz-Jorge C.

Front Surg. 2015 Jan 6;1:51. doi: 10.3389/fsurg.2014.00051. eCollection 2014. Review.

5.

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

van Dongen JJ, Lhermitte L, Böttcher S, Almeida J, van der Velden VH, Flores-Montero J, Rawstron A, Asnafi V, Lécrevisse Q, Lucio P, Mejstrikova E, Szczepański T, Kalina T, de Tute R, Brüggemann M, Sedek L, Cullen M, Langerak AW, Mendonça A, Macintyre E, Martin-Ayuso M, Hrusak O, Vidriales MB, Orfao A; EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708)..

Leukemia. 2012 Sep;26(9):1908-75. doi: 10.1038/leu.2012.120. Epub 2012 May 3.

6.

Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression.

Liu M, Wang L, Bongartz T, Hawse JR, Markovic SN, Schaid DJ, Mushiroda T, Kubo M, Nakamura Y, Kamatani N, Goss PE, Ingle JN, Weinshilboum RM.

Breast Cancer Res. 2012 Mar 9;14(2):R41.

7.

Matchmaking the B-cell signature of tolerance to regulatory B cells.

Chong AS, Sciammas R.

Am J Transplant. 2011 Dec;11(12):2555-60. doi: 10.1111/j.1600-6143.2011.03773.x. Epub 2011 Oct 3. Review.

8.

MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.

Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Fitzgibbon J, Staudt LM, Mueller-Hermelink HK, Calaminici M, Campo E, Ott G, Hernández L, Rosenwald A.

Blood. 2011 Nov 17;118(20):5550-8. doi: 10.1182/blood-2011-06-361972. Epub 2011 Sep 29.

9.

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.

Ingle JN, Schaid DJ, Goss PE, Liu M, Mushiroda T, Chapman JA, Kubo M, Jenkins GD, Batzler A, Shepherd L, Pater J, Wang L, Ellis MJ, Stearns V, Rohrer DC, Goetz MP, Pritchard KI, Flockhart DA, Nakamura Y, Weinshilboum RM.

J Clin Oncol. 2010 Nov 1;28(31):4674-82. doi: 10.1200/JCO.2010.28.5064. Epub 2010 Sep 27.

10.

Allogeneic hematopoietic cell transplant for prolymphocytic leukemia.

Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP, Gupta V, Maharaj D, Marks DI, Pavletic SZ, Horowitz MM, Arora M.

Biol Blood Marrow Transplant. 2010 Apr;16(4):543-7. doi: 10.1016/j.bbmt.2009.11.021. Epub 2009 Dec 2.

11.

The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.

Saji M, Ringel MD.

Mol Cell Endocrinol. 2010 May 28;321(1):20-8. doi: 10.1016/j.mce.2009.10.016. Epub 2009 Nov 6. Review.

12.

Accurate molecular classification of cancer using simple rules.

Wang X, Gotoh O.

BMC Med Genomics. 2009 Oct 30;2:64. doi: 10.1186/1755-8794-2-64.

13.

Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.

Lan K, Murakami M, Choudhuri T, Tsai DE, Schuster SJ, Wasik MA, Robertson ES.

J Clin Virol. 2008 Nov;43(3):260-5. doi: 10.1016/j.jcv.2008.07.018. Epub 2008 Sep 14.

14.

Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia.

Browning RL, Geyer SM, Johnson AJ, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Zent CS, Bone ND, Dewald GW, Lin TS, Heerema NA, Grever MR, Kay NE, Byrd JC, Lucas DM.

Leuk Res. 2007 Dec;31(12):1737-40. Epub 2007 Jul 19.

15.

Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

Shen RR, Ferguson DO, Renard M, Hoyer KK, Kim U, Hao X, Alt FW, Roeder RG, Morse HC 3rd, Teitell MA.

Blood. 2006 Sep 15;108(6):1991-8. Epub 2006 May 25.

16.

Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma.

Hoyer KK, French SW, Turner DE, Nguyen MT, Renard M, Malone CS, Knoetig S, Qi CF, Su TT, Cheroutre H, Wall R, Rawlings DJ, Morse HC 3rd, Teitell MA.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14392-7. Epub 2002 Oct 14.

17.

Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.

Künstle G, Laine J, Pierron G, Kagami Si S, Nakajima H, Hoh F, Roumestand C, Stern MH, Noguchi M.

Mol Cell Biol. 2002 Mar;22(5):1513-25.

Supplemental Content

Support Center